Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Receives $5.67 Average Price Target from Brokerages
Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Free Report) have been given a consensus rating of “Moderate Buy” by the six research firms that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average […]
More Stories
Fetch.ai Self Reported Market Capitalization Achieves $1.43 Billion (FET)
Fetch.ai (FET) traded 1.9% higher against the US dollar during the 24 hour period ending at 10:00 AM E.T. on...
Beese Fulmer Investment Management Inc. Has $612,000 Position in Kinder Morgan, Inc. (NYSE:KMI)
Beese Fulmer Investment Management Inc. raised its stake in Kinder Morgan, Inc. (NYSE:KMI – Free Report) by 3.7% in the...
Neutrino USD Tops 24-Hour Trading Volume of $1,435.15 (USDN)
Neutrino USD (USDN) traded 3.9% higher against the dollar during the 24 hour period ending at 10:00 AM ET on...
CENTRAL TRUST Co Trims Position in AbbVie Inc. (NYSE:ABBV)
CENTRAL TRUST Co lessened its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 2.0% in the third...
NULS Hits 24 Hour Trading Volume of $1.77 Million (NULS)
NULS (NULS) traded down 1.4% against the U.S. dollar during the twenty-four hour period ending at 10:00 AM Eastern on...
International Assets Investment Management LLC Acquires 3,249,594 Shares of Palo Alto Networks, Inc. (NASDAQ:PANW)
International Assets Investment Management LLC increased its holdings in Palo Alto Networks, Inc. (NASDAQ:PANW – Free Report) by 34,318.2% in...